Navigation Links
RBC Life Sciences Unveils the ClearPay System - the Industry's First Balancing Compensation Plan That Pays Quickly and Abundantly
Date:9/8/2009

IRVING, Texas, Sept. 8 /PRNewswire-FirstCall/ -- RBC Life Sciences, Inc. (OTC Bulletin Board: RBCL), a provider of proprietary nutritional supplements and wound care/pain management products, announced today that RBC Life has launched the ClearPay System, a compensation plan that rewards the company's independent Associates quickly, abundantly and deeply within their organizations.

The ClearPay System is the direct selling industry's first flex compensation plan that is balanced monthly by computer to maximize commission payouts to Associates. ClearPay allows Associates to build their organizations over five legs. Three of these are flex legs that Associates can move within their organization to reward or motivate members of their down lines.

RBC Life is the network marketing arm of publicly held RBC Life Sciences.

"We built the ClearPay System from the ground up to immediately reward and energize new Associates as they start to build their businesses," said RBC Life Sciences President and CEO, John W. Price.

"The ClearPay System rewards them earlier and better than other pay plans," he said. "We give them 10 ways to earn income while rewarding them immediately with direct commissions and power bonuses, supporting longterm income with dynamic matching and participation in qualified pool payouts."

RBC Life unveiled the ClearPay System during its 2009 North American Summit, a gathering of its independent North American sales force held August 14 and 15 in Dallas. The pay plan is the centerpiece of the company's focus on building its North American sales market.

As part of this effort, RBC Life recently introduced NeuroBright, the nutritional supplements industry's first cognitive function product of its kind. NeuroBright was shown in a recent animal study to improve test subjects' learning and memory by nearly 50 percent. NeuroBright is a synergistic blend of 11 herbal antioxidants and Microhydrin, RBC Life's super-antioxidant.

About RBC Life Sciences
RBC Life Sciences develops, manufactures and markets high-quality nutritional supplements and personal care products to a growing population of consumers seeking wellness and a healthy lifestyle. Under its MPM Medical brand, RBC Life Sciences also develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than 30 countries in which the products are distributed. For more information, visit the Company's Web site at www.rbclifesciences.com.

The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE RBC Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. RBC Life Sciences Launches New Initiatives Aimed at Building Its Network Marketing Business Across North America
2. Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference
3. Derma Sciences To Present at Rodman & Renshaws Eleventh Annual Healthcare Conference
4. Danaher to Acquire Life Sciences Instrumentation Businesses From MDS Inc. and Life Technologies Corporation
5. Blanchette Rockefeller Neurosciences Institute to Collaborate with Top Brain Injury Group
6. NxStage to Present at the UBS Global Life Sciences Conference
7. AMR Research Analyst Named One of the Most Inspiring Individuals in Life Sciences by PharmaVOICE
8. Advanced Life Sciences to Present at 11th Annual Rodman and Renshaw Healthcare Conference
9. Cell Biosciences Launches Unique Protein Phosphorylation Assay Service
10. Cumberland Pharmaceuticals to Present at UBS Global Life Sciences Conference in New York on September 21, 2009
11. Advanced Life Sciences Restanza Demonstrates Efficacy in Treating Anthrax Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... miniature, folded, pharmaceutical inserts and outserts. As a means of expanding capabilities ... addition will enable Flottman to individually code professional inserts (PIs) and patient package ...
(Date:12/9/2016)... NY (PRWEB) , ... December 09, 2016 , ... ... and Drug Dependence, Inc. (NCADD) is recommending the film Whispering Spirits ... and the District of Columbia as an education tool in the war against teen ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, Va., wanted ... all types of amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves ... use and could be set up in a matter of minutes, or even seconds. ...
(Date:12/9/2016)... ... 09, 2016 , ... The Holy Name Medical Center Foundation ... on December 3rd, to benefit Holy Name Medical Center's programs and services. More ... over $1 million - the largest event in the Center's history, both in ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying to get ... thought that if the nebulizer had a more child-friendly design, then children would be ... developed the patent-pending NEBY to avoid the need to deliver medication via a nebulizer ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... -- Australia Glaucoma Surgery Devices Market Outlook to ... Glaucoma Surgery Devices Market Outlook to 2022", provides ... Devices market. The report provides value, in millions ... prices (USD) within market segement - Glaucoma Drainage ... and distribution shares data for each of these ...
(Date:12/8/2016)... 2016 KEY FINDINGS The global ... 2017-2023. Various reasons for growth of the medical lifting ... of chronic diseases, high recovery cost of injuries and ... Medical lifting sling refers to an assistive device that ... slings connect to the lift and hold the patient. ...
(Date:12/8/2016)... Lilly and Company (NYSE: LLY ) today ... at the 9 th Clinical Trials on Alzheimer,s ... meet the primary endpoint in the EXPEDITION3 clinical trial, ... dementia due to Alzheimer,s disease (AD), and Lilly will ... of mild dementia due to AD. ...
Breaking Medicine Technology: